정밀진단 시장 규모, 점유율, 성장 분석 : 제품 유형별, 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Precision Diagnostics Market Size, Share, Growth Analysis, By Product Type (Consumables, Instruments), By Type (Genetic Tests, Direct to Consumer Tests), By Application, By End-User, By Region - Industry Forecast 2025-2032
상품코드:1630729
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 정밀진단 시장 규모는 2023년에 680억 7,000만 달러에 달하며, 2024년 805억 9,000만 달러에서 2032년에는 3,112억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 18.4%로 성장할 전망입니다.
정밀진단은 특히 당뇨병과 암 치료에서 환자의 건강 문제에 대한 맞춤형 인사이트을 적시에 제공함으로써 헬스케어에 혁명을 일으키고 있습니다. 암과 신경질환의 발병률이 증가함에 따라 정밀의료에 대한 수요가 급증하고 있습니다. 미국 국립암연구소는 2031년까지 신규 암 환자가 2,950만 명 증가하고, 암 관련 사망자 수가 1,640만 명 증가할 것으로 예측했습니다. 암, 결핵, 알츠하이머병 등의 질병에 대한 유전자 치료와 정밀 치료의 발전은 상당한 매출 증가를 가져올 것으로 예상됩니다. 정밀진단 및 치료법의 맞춤화 가능성은 중요한 장점으로, 일반적인 솔루션이 아닌 맞춤 치료 접근법을 가능하게 하여 환자 결과와 의료 효율성을 향상시킬 수 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
기술의 진보
규제 상황
특허 분석
정밀진단 시장 규모 : 제품 유형별
시장 개요
소모품
시약
키트
어세이
기기
차세대 시퀀싱(NGS) 시스템
중합효소 연쇄 반응(PCR) 시스템
질량분석 시스템
기타
소프트웨어와 서비스
데이터 분석 소프트웨어
바이오인포매틱스 서비스
컨설팅 서비스
정밀진단 시장 규모 : 유형별
시장 개요
유전자 검사
소비자용 검사
에소테릭 검사
기타
정밀진단 시장 규모 : 용도별
시장 개요
종양학
유방암
폐암
대장암
기타
심장병학
신경학
감염증
기타
정밀진단 시장 규모 : 최종사용자별
시장 개요
병원
진단 검사실
조사기관
기타
정밀진단 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024년)
주요 기업 개요
Roche(Switzerland)
GE Healthcare(United States)
Abbott Laboratories(United States)
Philips Healthcare(Netherlands)
Danaher Corporation(United States)
Quest Diagnostics(United States)
Fujifilm Medical(Japan)
Becton, Dickinson and Company(United States)
Siemens Healthineers(Germany)
Hologic Inc.(United States)
QIAGEN(Germany)
Grifols(Spain)
Beckman Coulter(United States)
bioMerieux(France)
Thermo Fisher Scientific(United States)
PerkinElmer(United States)
Illumina(United States)
Agilent Technologies(United States)
Bio-Rad Laboratories(United States)
Merck Group(Germany)
결론과 권장사항
KSA
영문 목차
영문목차
Global Precision Diagnostics Market size was valued at USD 68.07 billion in 2023 and is poised to grow from USD 80.59 billion in 2024 to USD 311.26 billion by 2032, growing at a CAGR of 18.4% during the forecast period (2025-2032).
Precision diagnostics is revolutionizing healthcare by providing tailored, timely insights into patients' health issues, particularly in diabetes and cancer treatment. Given the escalating incidence of cancer and neurological disorders, demand for precision medicine is set to soar. The National Cancer Institute projects a staggering increase of 29.5 million new cancer cases by 2031, alongside a 16.4 million rise in cancer-related fatalities. Advances in gene therapy and precision treatments for conditions like cancer, tuberculosis, and Alzheimer's are expected to drive significant revenue growth. The customizable nature of precision diagnostics and therapies is a critical advantage, allowing for personalized treatment approaches rather than a generic solution, thereby enhancing patient outcomes and healthcare efficiency.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Precision Diagnostics Market Segmental Analysis
Global Precision Diagnostics Market is segmented by Product Type, Type, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software & Services. Based on Type, the market is segmented into Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Others. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Infectious Diseases and Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Precision Diagnostics Market
The Global Precision Diagnostics market is being driven significantly by the rising demand for personalized therapy, which has gained traction in recent years. Essential tools such as genetic testing and genome sequencing are pivotal in unraveling the molecular foundations of various diseases. In many European nations, there is a proactive approach to screening for genetic disorders, as early detection can mitigate symptoms and lessen disease severity. Additionally, the COVID-19 pandemic highlighted the importance of diagnostic testing in managing outbreaks. Pharmaceutical and biotech firms are actively pursuing preclinical and clinical trials for innovative therapies, including plasma and immunotherapy. This momentum is expected to fuel market growth throughout the forecast period.
Restraints in the Global Precision Diagnostics Market
The Global Precision Diagnostics market faces several restraints that could impede its growth potential, primarily due to a lack of awareness and substantial costs associated with research and development. High R&D expenses deter innovation and advancement in precision diagnostics. While accurate diagnosis remains a top priority for healthcare providers, challenges such as the demand for quicker test results, inefficiencies in current testing methods, and regulatory hurdles for new test kit development further complicate market progress. Additionally, the strict regulatory landscape in many nations continues to pose significant barriers, ultimately hampering the overall expansion of the precision diagnostics sector.
Market Trends of the Global Precision Diagnostics Market
The Global Precision Diagnostics market is experiencing a significant upward trend, driven primarily by the alarming increase in cancer prevalence worldwide. As cancer cases rise, there is an intensified focus on enhancing detection, prevention, and treatment protocols. Innovations such as Next Generation Sequencing (NGS) and the integration of extensive genomic data are revolutionizing the diagnostic landscape, leading to more tailored and effective therapeutic strategies. This fusion of technological advancements and a growing demand for precision medicine is poised to fuel robust growth in the market throughout the forecast period, positioning it as a critical component of modern healthcare solutions.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Patent Analysis
Global Precision Diagnostics Market Size by Product Type & CAGR (2025-2032)
Market Overview
Consumables
Reagents
Kits
Assays
Instruments
Next-Generation Sequencing (NGS) Systems
Polymerase Chain Reaction (PCR) Systems
Mass Spectrometry Systems
Others
Software & Services
Data Analysis Software
Bioinformatics Services
Consulting Services
Global Precision Diagnostics Market Size by Type & CAGR (2025-2032)
Market Overview
Genetic Tests
Direct to Consumer Tests
Esoteric Tests
Others
Global Precision Diagnostics Market Size by Application & CAGR (2025-2032)
Market Overview
Oncology
Breast Cancer
Lung Cancer
Colorectal Cancer
Others
Cardiology
Neurology
Infectious Diseases
Others
Global Precision Diagnostics Market Size by End-User & CAGR (2025-2032)
Market Overview
Hospitals
Diagnostic Laboratories
Research Institutes
Others
Global Precision Diagnostics Market Size & CAGR (2025-2032)
North America (Product Type, Type, Application, End-User)
US
Canada
Europe (Product Type, Type, Application, End-User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Type, Application, End-User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Type, Application, End-User)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Type, Application, End-User)
